Modifiable risk factors impact CVD mortality in T2DM

July 14, 2014
Modifiable risk factors impact CVD mortality in T2DM

(HealthDay)—Modifiable risk factors can be targeted for early and continued intervention to reduce the risk of adverse outcomes in patients with type 2 diabetes mellitus and cardiovascular disease, according to research published online July 2 in Diabetes Care.

Amanda J. Cox, Ph.D., of the Wake Forest School of Medicine in Winston-Salem, N.C., and colleagues analyzed data for a subset of 371 high-risk patients from the Diabetes Heart Study with type 2 diabetes and a coronary artery calcified plaque score greater than 1,000 mg. The researchers compared differences in (CVD) risk factors among 218 living and 153 deceased participants.

The researchers found that duration of type 2 diabetes had been longer (P = 0.02) and use of cholesterol-lowering medications lower (P = 0.004) among deceased participants. After adjustment, vascular calcified plaque scores were found to be associated with higher risk of mortality. Other CVD risk factors found to be associated with 1.1 to 1.5 times higher risk of mortality included higher levels of HbA1c, lipids, and C-reactive protein and reduced kidney function.

"In conclusion, the findings described here suggest that even among individuals with type 2 diabetes and high burden of subclinical CVD, modifiable exist that could be targeted for early and continued intervention to reduce the risk of ," the authors write.

Explore further: Significant differences in CVD risk factors between men and women with type 2 diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Significant differences in CVD risk factors between men and women with type 2 diabetes

May 15, 2014
Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly ...

Serum marker predicts cardiovascular events in diabetes

April 25, 2014
(HealthDay)—Elevated levels of polyclonal serum immunoglobulin combined free light chains (cFLCs) may indicate adverse cardiovascular disease (CVD) outcomes in patients with type 2 diabetes, according to research published ...

Health behavior change cuts CVD risk after T2DM diagnosis

March 31, 2014
(HealthDay)—For adults newly diagnosed with type 2 diabetes, adoption of healthy behavior changes is associated with reduced cardiovascular disease (CVD) risk, according to a study published online March 21 in Diabetes ...

Blood glucose measure appears to provide little benefit in predicting risk of CVD

March 25, 2014
In a study that included nearly 300,000 adults without a known history of diabetes or cardiovascular disease (CVD), adding information about glycated hemoglobin (HbA1c), a measure of longer-term blood sugar control, to conventional ...

Heart health matters to your brain

June 4, 2013
June 4, 2013 – People suffering from type 2 diabetes and cardiovascular disease (CVD) are at an increased risk of cognitive decline, according to a new study from Wake Forest Baptist Medical Center.

Interarm BP difference may up cardiac risk in diabetes

April 3, 2014
(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March ...

Recommended for you

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

Gene therapy restores normal blood glucose levels in mice with type 1 diabetes

January 4, 2018
Type 1 diabetes is a chronic disease in which the immune system attacks and destroys insulin-producing beta cells in the pancreas, resulting in high blood levels of glucose. A study published January 4th in Cell Stem Cell ...

Goodbye, needles? Patch might be the future for blood-sugar tracking

January 4, 2018
(HealthDay)—Developers of a new patch hope to eliminate a big barrier in type 2 diabetes treatment—painful finger-sticks and injections. The new patch—which actually uses an array of tiny needles that researchers promise ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.